Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on August 26, 2026

Refresh: Florida Lip Filler Searches Rise 16% as Natural Results Take Over
Ignite Market Access Launches to Help Healthcare Medical Supply Companies Accelerate Commercial Growth
CURIS System Launches the BMS Link System™: Where Portability Meets Integration
Melissa Methven's Calm Chair System Helps Dental Practices Ease Stress in the Chair
Health Conditions That Qualify Seniors to Sell a Life Insurance Policy: New Guide From Citizens Life Group
Holistic Transformational Coach Suzan Choi Seluzte Lee of Lotus Flower Design Recently Featured on Close Up Radio
Dr. Bonnie McLean of Spirit Gate Medicine Recently Featured on Close Up Radio
ClaimsRevenue™ Announces September 1 Launch of New Claims Revenue Platform for Independent Healthcare Practices
Dr. J. David Holcomb Celebrates 25 Years of Facial Plastic Surgery Excellence in Sarasota
Onco360® Has Been Selected as a National Pharmacy Partner for RASONQUE™ (daraxonrasib)
Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions
Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients
First Tracks Biotherapeutics Announces Participation in September Investor Conferences
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology
Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting
Xenon to Highlight Phase 3 X-TOLE2 Clinical Data and Rational Polytherapy Potential for Azetukalner at EEC 2026
U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
Johns Hopkins-led study supported by Truveta Data earns NIH R01 grant for GLP-1 research
JAMA Dermatology Publishes Skin-Specific Outcomes from Phase 3 VALOR Trial Of Brepocitinib in Dermatomyositis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Florida Health Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.